France's Ipsos reports steady Q3 revenue, lifts 2026 growth forecast

By Reuters News


Overview

  • France-based market research firm's Q3 revenue was flat yr/yr, with organic growth of 2.0%

  • Company raised 2026 organic growth outlook to 1.2%-1.5% amid ongoing macro and geopolitical uncertainty

  • Kelly Beaver appointed CEO, with focus on accelerating Horizons strategic plan


Outlook

  • Ipsos sees 2026 organic growth between 1.2% and 1.5%

  • Ipsos expects 2026 operating margin rate to be in line with 2025

  • Company says outlook reflects ongoing macroeconomic and geopolitical uncertainty, especially in Middle East


Result Drivers

  • REGIONAL PERFORMANCE - Co said organic growth was driven by strong results in EMEA, China and Citizens business

  • CITIZENS SEGMENT - Co said contract wins and renewed interest from decision-makers boosted Citizens segment growth

  • PHARMA DEMAND - Co said growth in Doctors & Patients segment was supported by new drug approvals and pharma innovation


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

EUR 636.20 mln

Q3 Organic Growth

2.00%


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the advertising & marketing peer group is "buy"

  • Wall Street's median 12-month price target for Ipsos SA is €50.00, about 33.8% above its October 22 closing price of €37.38

  • The stock recently traded at 7 times the next 12-month earnings vs. a P/E of 6 three months ago


Reuters Recommended Reads

  • Oct 21 - French betting group FDJ United's 9M revenue falls on fewer jackpots and tax hikes; cuts FY outlook

  • Oct 21 - France's Fnac Darty Q3 revenue rises on strong European growth

  • Oct 22 - Gucci sales slip again in latest blow to Kering recovery plan


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.